MAPT and Alzheimer disease: Research on 3 transgenic AD mouse models, revealed that the anti‐apoptotic Bcl‐2 gene resulted in the inhibition of caspase‐dependent cleavage of tau, inhibition of plaques and tangles formation, and improvement of memory.123